CoChat

N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis

Duailibi, Michel Silvio, Cordeiro, Quirino, Brietzke, Elisa, Ribeiro, Marcelo, LaRowe, Steve, Berk, Michael, Trevizol, Alisson Paulino · 2017 · The American Journal on Addictions
Cited by 82

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Background and Objectives: Recent neurobiological evidences along with clinical observations justify the use of N‐acetylcysteine (NAC) as a medication for craving. The objective of our study was to assess the evidence of efficacy of NAC for craving in substance use disorders in randomized clinical trials (RCTs). Methods: Systematic review of the RCTs literature (PROSPERO number 56698) until February, 2017, using MEDLINE, Cochrane Library and clinicaltrials.gov. We included seven RCTs (n = 245); most with small‐to‐moderate sample sizes. The main outcome was the Hedges’ g for continuous scores in a random‐effects model. Heterogeneity was evaluated with the I2 and the χ2 test. Publication bias was evaluated using the Begg's funnel plot and the Egger's test. Meta‐regression was performed using the random‐effects model. Results: Comparing NAC versus placebo, NAC was significantly superior for craving symptoms (Hedges’ g = 0.94; 95%CI 0.55–1.33). The funnel plot showed the risk of publication bias was low and between‐study heterogeneity was not significant (I2 = 44.4%, p = 0.07 for the χ2 test). A subgroup analysis performed using meta‐regression showed no particular influence. Discussion and Conclusions: NAC was superior to placebo for craving reduction in SUDs. The relatively small number of trials and their heterogeneous methodology were possible limitations; however, these positive thrilling results stimulate further studies for clarifying the potential impact of NAC for craving symptoms in SUDs.Scientific Significance: The safety profile of NAC and favorable tolerability, in addition to being an over‐the‐counter medication, presents with an interesting potential clinical use for craving in SUDs. Scientific Significance: The safety profile of NAC and its favorable tolerability, in addition to being anover‐the‐counter medication, presents with an interesting potential clinical use for craving in SUDs. (Am J Addict 2017;26:660–666)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ajad.12620

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 82

Metadata

Authors
Duailibi, M. S., Cordeiro, Q., Brietzke, E., Ribeiro, M., LaRowe, S., Berk, M., & Trevizol, A. P.
Venue
The American Journal on Addictions
Publisher
Wiley
Published
2017-09-12
Volume
26
Issue
7
Pages
660-666
ISSN
  • 1055-0496 (ISSN-L)
  • 1521-0391
OpenAlex
W2756375477
Cited by
82
References
13
FWCI
1.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/ajad.12620
The paper
Duailibi, M. S., Cordeiro, Q., Brietzke, E., Ribeiro, M., LaRowe, S., Berk, M., & Trevizol, A. P. (2017). N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis. The American Journal on Addictions. https://doi.org/10.1111/ajad.12620

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.